Small, frequent meals of bland, protein-rich foods help
Refrigeration at 28C slows these degradation pathways to negligible rates
Sarah Khan , Brian Kang, and Dr
In March 2026, Hims settled with Novo Nordisk and exited compounded semaglutide for new patients, pivoting to branded Wegovy and Zepbound.[7] The platform now offers injectable Wegovy at $299/month, oral Wegovy at $249/month, and Zepbound at $399/month, with commercial insurance bringing costs to $0$25/month for eligible patients
Sem-O Therapeutic Segment: Anti-Diabetic Generic Name: Semaglutide Indication Tablet 3mg 7mg 14mg Sem-O Tablet is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise: As monotherapy when metformin is considered inappropriate due to intolerance or contraindications